@neurIST

Towards integrative decision support systems for personalised brain aneurysm rupture risk assessment and treatment.

When considered separately from other cardiovascular diseases, stroke ranks third among all causes of death, after heart disease and cancer.Worldwide, 3 million women and 2.5 million men die each year from stroke. Hemorrhagic stroke occurs when a blood vessel, typically an aneurysm, ruptures inside the brain. This often leads to severe disability or death. Despite considerable advances in treatment, rupture is associated with exceptionally high levels of morbidity and mortality - about 33% in each case.

Currently, invasive or minimally invasive treatment is offered to almost all patients because there is insufficient evidence to support a decision of nonintervention. It is the primary thesis of @neurIST that the process of cerebral aneurysm diagnosis, treatment planning and development is significantly compromised by the fragmentation of relevant data.To address this issue, @neurIST is developing a complete IT infrastructure for the management and processing of heterogeneous data associated with the diagnosis and treatment of cerebral aneurysms.

@neurIST will transform the management of cerebral aneurysms by providing new insight, personalised risk assessment and methods for the design of improved medical devices and treatment protocols.

For further information, please visit:
http://www.aneurist.org

Project co-ordinator:
Universitat Pompeu Fabra

Partners:
Universitat Pompeu Fabra, Université de Genève, The University of Sheffield, Ecole Polytechnique Fédérale de Lausanne, Fraunhofer Institute, Institut Municipal d'Assistència Sanitària, Super Computing Solutions, Philips Medical Systems, Erasmus Medical Center, Royal Institute of Technology, GridSystems, ANSYS, NEC, University of Oxford, InferMed, Advanced Simulation & Design, William Cook, Institut National de la Santé et la Recherche Médicale, IDAC, Neuroangiografia Terapèutica, Hospital Clínic de Barcelona, University of Bedfordshire, Medical University of Pécs, Universitaet Wien, Universitätsklinikum Freiburg, Durham University, King's College London.

Timetable: from 01/06 - to 12/09

Total cost: € 17.356.730,92

EC funding: € 12.605.239

Instrument: IP

Project Identifier: IST-2004-027703

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...